Answers are grounded in this paper and cite their sources.
Patients receiving tPA for pulmonary embolism require rigorous nursing assessment, including vital signs and neurologic checks every 15-60 minutes for 24 hours, to monitor for bleeding and allergic complications.
Q Is there a protocol for nursing assessment (neurologic and vital signs) after infusion of 50 to 100 mg of tissue plasminogen activator (tPA) specifically for pulmonary embolism (PE)? Little is written about tPA and PE assessments, as opposed to the higher dosing of tPA for strokes, for which there are many available protocols.A Melissa McLenon, DNP, ACNP-BC, replies:Pulmonary embolism (PE) is the third-leading cause of cardiovascular death in the United States.1 Over the past few decades, there has been much debate regarding the use of thrombolytic therapy, such as recombinant tPA, also known as alteplase, in the treatment of PE. Thrombolytic agents convert native plasminogen to plasmin, which in turn hydrolyzes the fibrin of thromboemboli, resulting in clot lysis. The risks and benefits of administering thrombolytics must be weighed carefully. For massive PE, the benefits of systemic thrombolysis generally outweigh the risks.Tissue plasminogen activator is the most common thrombolytic used for treatment of PE and has been approved by the US Food and Drug Administration at a dose of 100 mg infused over 2 hours.2 However, the dose of tPA has also been a topic of debate, as the risk of bleeding complications is dose dependent, with lower doses associated with less risk. Studies have shown that lower doses of tPA can be both safe and effective in the treatment of high-risk patients with PE.1,3 Thus, it is important to identify patients at greatest risk of bleeding complications following thrombolysis.Several guidelines have been published on the nursing management and monitoring of patients who receive tPA for acute stroke.4,5 However, no guidelines are currently available on the management of patients receiving tPA for PE. The dose for acute stroke and the dose for PE are similar: The dose for acute stroke is 0.9 mg/kg, with a maximum dose of 90 mg, whereas the dose for PE is typically between 50 and 100 mg.2,5 In both cases, tPA is administered intravenously, so the monitoring is similar and should follow current guidelines. The difference is that patients with acute stroke are at greater risk of hemorrhagic conversion of the stroke, and thus more rapid neurologic deterioration, whereas patients with PE are at risk of respiratory deterioration or pulmonary hemorrhage.Patients receiving tPA should be monitored in an intensive care unit for at least 24 hours during and after infusion.6 Monitoring of patients who receive thrombolytic therapy, regardless of the indication, includes assessing vital signs every 15 minutes for the first 2 hours at the beginning of tPA infusion, then every 30 minutes for 6 hours, then every 60 minutes for 16 hours (total of 24 hours).7 Blood pressure control is a priority in patients receiving thrombolytic therapy. The target systolic blood pressure for patients receiving tPA for acute stroke is less than 185 mm Hg. No specific guidelines for blood pressure control in patients with PE exist; however, a specific blood pressure goal can be determined in collaboration with a prescribing clinician on the basis of the patient’s hemodynamic stability.Neurologic checks should be done at the same intervals as assessment of vital signs, as the risk of intracranial hemorrhage is increased in patients receiving thrombolytic therapy.6 Factors that increase the risk of intracranial hemorrhage and bleeding include advanced age (>70 years old), weight less than 50 kg, uncontrolled hypertension, recent surgery, and history of prior stroke.8 The prescribing clinician must be notified immediately of any signs of neurologic deterioration, including a sudden change in consciousness; a drop in Glasgow Coma Scale score; unequal pupil size; onset of drowsiness, nausea, vomiting, or photophobia; increase in blood pressure; and decrease in heart rate.All intravenous and arterial access sites should be established before the administration of tPA, and nursing assessment includes the assessment of puncture sites for bleeding. If possible, intramuscular injections and trauma to the patient should be avoided. Fatal cases of hemorrhage associated with traumatic intubation and bladder trauma in patients undergoing thrombolytic therapy have occurred. Therefore, if these interventions are necessary, they should be performed before administration of thrombolytic therapy. The nurse should also assess body fluids, including urine, vomitus, and feces, for evidence of bleeding. Monitoring hemoglobin, hematocrit, prothrombin time, and partial thromboplastin time is required at regular intervals as determined by the prescribing clinician.9Patients receiving tPA must also be monitored for allergic or anaphylactic reactions to the medication. Allergic type reactions such as anaphylactoid reaction, laryngeal edema, orolingual angioedema, rash, and urticaria have been reported.5,7 Orolingual angioedema has been observed during and up to 2 hours after infusion. Patients receiving concomitant angiotensin-converting enzyme inhibitors are at greatest risk.7 If any of these conditions develop, the prescribing clinician should be notified immediately.Astute nursing assessment is critical to the outcomes of patients receiving thrombolytic therapy. Because patients with massive PE are already critically ill, they require thorough assessment and frequent monitoring by the bedside nurse. Subtle changes can indicate a life-threatening complication in patients undergoing thrombolytic therapy. It is the nurse’s responsibility to detect these changes and communicate with the prescribing clinician. Nursing care also includes educating the patient and the family about signs and symptoms to report and providing support for them during this stressful time.
No takes yet. Share an insight, caveat, or question.
Melissa McLenon (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: